177 related articles for article (PubMed ID: 12404222)
1. Prognostic significance of calcium-binding protein S100A4 in colorectal cancer.
Gongoll S; Peters G; Mengel M; Piso P; Klempnauer J; Kreipe H; von Wasielewski R
Gastroenterology; 2002 Nov; 123(5):1478-84. PubMed ID: 12404222
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of S100A4 mRNA and protein expression in colorectal cancer.
Kang YG; Jung CK; Lee A; Kang WK; Oh ST; Kang CS
J Surg Oncol; 2012 Feb; 105(2):119-24. PubMed ID: 21837681
[TBL] [Abstract][Full Text] [Related]
3. Expression of protein S100A4 is a predictor of recurrence in colorectal cancer.
Kwak JM; Lee HJ; Kim SH; Kim HK; Mok YJ; Park YT; Choi JS; Moon HY
World J Gastroenterol; 2010 Aug; 16(31):3897-904. PubMed ID: 20712050
[TBL] [Abstract][Full Text] [Related]
4. S100 calcium-binding protein A4 is a novel independent prognostic factor for the poor prognosis of gastric carcinomas.
Zhao Y; Zhang T; Wang Q
Oncol Rep; 2013 Jul; 30(1):111-8. PubMed ID: 23612849
[TBL] [Abstract][Full Text] [Related]
5. Clinical significance of E-cadherin, β-catenin, vimentin and S100A4 expression in completely resected squamous cell lung carcinoma.
Zhang H; Liu J; Yue D; Gao L; Wang D; Zhang H; Wang C
J Clin Pathol; 2013 Nov; 66(11):937-45. PubMed ID: 23853314
[TBL] [Abstract][Full Text] [Related]
6. Metastasis-associated protein S100A4--a potential prognostic marker for colorectal cancer.
Hemandas AK; Salto-Tellez M; Maricar SH; Leong AF; Leow CK
J Surg Oncol; 2006 May; 93(6):498-503. PubMed ID: 16615153
[TBL] [Abstract][Full Text] [Related]
7. Clinicopathologic significance of S100A4 expression in osteosarcoma.
Cao CM; Yang FX; Wang PL; Yang QX; Sun XR
Eur Rev Med Pharmacol Sci; 2014; 18(6):833-9. PubMed ID: 24706307
[TBL] [Abstract][Full Text] [Related]
8. Increased expressions of SATB1 and S100A4 are associated with poor prognosis in human colorectal carcinoma.
Niu Y; Wang L; Cheng C; Du C; Lu X; Wang G; Liu J
APMIS; 2015 Feb; 123(2):93-101. PubMed ID: 25257341
[TBL] [Abstract][Full Text] [Related]
9. Nuclear S100A4 is a novel prognostic marker in colorectal cancer.
Boye K; Nesland JM; Sandstad B; Mælandsmo GM; Flatmark K
Eur J Cancer; 2010 Nov; 46(16):2919-25. PubMed ID: 20719498
[TBL] [Abstract][Full Text] [Related]
10. Enhanced S100A4 protein expression is clinicopathologically significant to metastatic potential and p53 dysfunction in colorectal cancer.
Kim JH; Kim CN; Kim SY; Lee JS; Cho D; Kim JW; Yoon SY
Oncol Rep; 2009 Jul; 22(1):41-7. PubMed ID: 19513503
[TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of the metastasis-inducing protein S100A4 (p9Ka) in human breast cancer.
Rudland PS; Platt-Higgins A; Renshaw C; West CR; Winstanley JH; Robertson L; Barraclough R
Cancer Res; 2000 Mar; 60(6):1595-603. PubMed ID: 10749128
[TBL] [Abstract][Full Text] [Related]
12. Combined expression of S100A4 and Annexin A2 predicts disease progression and overall survival in patients with urothelial carcinoma.
Zhang Q; Zhao Z; Ma Y; Wang H; Ma J; He X; Zhang D
Urol Oncol; 2014 Aug; 32(6):798-805. PubMed ID: 24968947
[TBL] [Abstract][Full Text] [Related]
13. S100A4 over-expression underlies lymph node metastasis and poor prognosis in colorectal cancer.
Huang LY; Xu Y; Cai GX; Guan ZQ; Sheng WQ; Lu HF; Xie LQ; Lu HJ; Cai SJ
World J Gastroenterol; 2011 Jan; 17(1):69-78. PubMed ID: 21218086
[TBL] [Abstract][Full Text] [Related]
14. S100A4 expression is a prognostic indicator in small intestine adenocarcinoma.
Roh J; Knight S; Chung JY; Eo SH; Goggins M; Kim J; Cho H; Yu E; Hong SM
J Clin Pathol; 2014 Mar; 67(3):216-21. PubMed ID: 24062356
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the metastasis-inducing protein S100A4 (p9ka) with other prognostic markers in human breast cancer.
Platt-Higgins AM; Renshaw CA; West CR; Winstanley JH; De Silva Rudland S; Barraclough R; Rudland PS
Int J Cancer; 2000 Mar; 89(2):198-208. PubMed ID: 10754500
[TBL] [Abstract][Full Text] [Related]
16. Expression of S100A4 and Met: potential predictors for metastasis and survival in early-stage breast cancer.
Lee WY; Su WC; Lin PW; Guo HR; Chang TW; Chen HH
Oncology; 2004; 66(6):429-38. PubMed ID: 15452371
[TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of S100A4 expression in stage II and III colorectal cancer: results from a population-based series and a randomized phase III study on adjuvant chemotherapy.
Boye K; Jacob H; Frikstad KA; Nesland JM; Maelandsmo GM; Dahl O; Nesbakken A; Flatmark K
Cancer Med; 2016 Aug; 5(8):1840-9. PubMed ID: 27273130
[TBL] [Abstract][Full Text] [Related]
18. Podoplanin, α-smooth muscle actin or S100A4 expressing cancer-associated fibroblasts are associated with different prognosis in colorectal cancers.
Choi SY; Sung R; Lee SJ; Lee TG; Kim N; Yoon SM; Lee EJ; Chae HB; Youn SJ; Park SM
J Korean Med Sci; 2013 Sep; 28(9):1293-301. PubMed ID: 24015033
[TBL] [Abstract][Full Text] [Related]
19. Combined aberrant expression of E-cadherin and S100A4, but not β-catenin is associated with disease-free survival and overall survival in colorectal cancer patients.
Lee SJ; Choi SY; Kim WJ; Ji M; Lee TG; Son BR; Yoon SM; Sung R; Lee EJ; Youn SJ; Park SM
Diagn Pathol; 2013 Jun; 8():99. PubMed ID: 23783026
[TBL] [Abstract][Full Text] [Related]
20. High-level expression of S100A4 correlates with lymph node metastasis and poor prognosis in patients with gastric cancer.
Wang YY; Ye ZY; Zhao ZS; Tao HQ; Chu YQ
Ann Surg Oncol; 2010 Jan; 17(1):89-97. PubMed ID: 19820999
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
